Higher methylation subtype of malignant melanoma and its correlation with thicker progression and worse prognosis
Abstract Malignant melanoma (MM) is the most life‐threatening disease among all skin malignancies, and recent genome‐wide studies reported BRAF, RAS, and NF1 as the most frequently mutated driver genes. While epigenetic aberrations are known to contribute to the oncogenic activity seen in various ca...
Saved in:
| Main Authors: | Yosuke Yamamoto, Keisuke Matsusaka, Masaki Fukuyo, Bahityar Rahmutulla, Hiroyuki Matsue, Atsushi Kaneda |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-10-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.3127 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epigenetic Therapies in Melanoma—Targeting DNA Methylation and Histone Modification
by: Adrian Bogdan Tigu, et al.
Published: (2025-05-01) -
A qualitative prognostic biomarker for melanoma based on the relative methylation orderings of CpG loci
by: Yue Huo, et al.
Published: (2025-12-01) -
DNA methylation variations of DNA damage response correlate survival and local immune status in melanomas
by: Min Wang, et al.
Published: (2024-09-01) -
Cyclin-Dependent Kinase Inhibitors in the Rare Subtypes of Melanoma Therapy
by: Jonatan Kaszubski, et al.
Published: (2024-11-01) -
Integrated multi-omics profiling reveals the role of the DNA methylation landscape in shaping biological heterogeneity and clinical behaviour of metastatic melanoma
by: Andrea Anichini, et al.
Published: (2025-07-01)